Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1461
Embargo will expire:
23-Jul-2018 11:00 AM EDT
Released to reporters:
20-Jul-2018 2:35 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jul-2018 11:00 AM EDT

Embargo will expire:
25-Jul-2018 4:00 PM EDT
Released to reporters:
19-Jul-2018 4:35 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2018 4:00 PM EDT

  • Embargo expired:
    18-Jul-2018 4:00 PM EDT

Article ID: 697421

Pregnancy History May Be Tied to Alzheimer’s Disease

American Academy of Neurology (AAN)

A woman’s history of pregnancy may affect her risk of Alzheimer’s disease decades later, according to a study published in the July 18, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released:
13-Jul-2018 3:55 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
TwymanPhoto.jpg

Article ID: 697574

Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

NeuroVision

Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years’ experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Inc. Board of Directors on July 20.

Released:
18-Jul-2018 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697594

Proteomics Studies on the Basic Biology of Alzheimer’s, Cancer and Listeriosis

American Society for Biochemistry and Molecular Biology (ASBMB)

Recent articles in the journal Molecular & Cellular Proteomics investigate metabolic quirks of cancer cells, other roles for the enzyme that generates amyloid beta, and the action mechanism of a bacterial toxin.

Released:
18-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697551

New Coalition of Philanthropists Including Bill Gates and Leonard Lauder Commit More Than $30 Million to Develop New Tools to Diagnose Alzheimer's Disease

Alzheimer's Drug Discovery Foundation

Philanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's disease and related dementias.

Released:
17-Jul-2018 1:20 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
7-17-2018Chanapa-1.jpg

Article ID: 697481

Majority of Older Adults with Probable Dementia Are Likely Unaware They Have It, Study Suggests

Johns Hopkins Medicine

A Johns Hopkins Medicine analysis of information gathered for an ongoing and federally sponsored study of aging and disability adds to evidence that a substantial majority of older adults with probable dementia in the United States have never been professionally diagnosed or are unaware they have been.

Released:
17-Jul-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
NewBrain.jpeg

Article ID: 697413

Aphasia: A Disruption in Communication

LifeBridge Health

Most people who are familiar with the term associate it with stroke (i.e., brain damage caused by disrupted blood flow to the brain). But aphasia, an impairment of language, is not always caused by stroke.

Released:
13-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697372

Novel Therapy Delays Muscle Atrophy in Lou Gehrig’s Disease Model

Case Western Reserve University

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.

Released:
12-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697325

Practice Imperfect: Repeated Cognitive Testing Can Obscure Early Signs of Dementia

University of California San Diego Health

Alzheimer’s disease is a progressive, neurodegenerative condition that often begins with mild cognitive impairment (MCI), making early and repeated assessments of cognitive change crucial to diagnosis and treatment. In a paper in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, researchers led by scientists at the University of California San Diego School of Medicine found that repeated testing of middle-age men produced a “practice effect” which obscured true cognitive decline and delayed detection of MCI.

Released:
11-Jul-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1461





Chat now!